Cargando…
Drug Dosing Recommendations for All Patients: A Roadmap for Change
Most drug labels do not contain dosing recommendations for a significant portion of real‐world patients for whom the drug is prescribed. Current label recommendations predominately reflect the population studied in pivotal trials that typically exclude patients who are very young or old, emaciated o...
Autores principales: | Powell, J. Robert, Cook, Jack, Wang, Yaning, Peck, Richard, Weiner, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818440/ https://www.ncbi.nlm.nih.gov/pubmed/32453862 http://dx.doi.org/10.1002/cpt.1923 |
Ejemplares similares
-
Science‐Based Approach to Harmonize Contraception Recommendations in Clinical Trials and Pharmaceutical Labels
por: Bowman, Christopher J., et al.
Publicado: (2022) -
Consideration of a Credibility Assessment Framework in Model‐Informed Drug Development: Potential Application to Physiologically‐Based Pharmacokinetic Modeling and Simulation
por: Kuemmel, Colleen, et al.
Publicado: (2019) -
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4–5 December 2014)
por: Musuamba, FT, et al.
Publicado: (2017) -
Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
por: Blum, Alexander B, et al.
Publicado: (2011) -
Quality Controls in Ligand Binding Assays: Recommendations and Best Practices for Preparation, Qualification, Maintenance of Lot to Lot Consistency, and Prevention of Assay Drift
por: Azadeh, Mitra, et al.
Publicado: (2019)